- Home
- OFLX vs BNTC Comparison
OFLX vs BNTC Comparison
Compare OFLX & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OFLX
- BNTC
- Stock Information
- Founded
- OFLX 1975
- BNTC 1995
- Country
- OFLX United States
- BNTC United States
- Employees
- OFLX N/A
- BNTC N/A
- Industry
- OFLX Industrial Specialties
- BNTC Biotechnology: Pharmaceutical Preparations
- Sector
- OFLX Industrials
- BNTC Health Care
- Exchange
- OFLX Nasdaq
- BNTC Nasdaq
- Market Cap
- OFLX 366.4M
- BNTC 335.5M
- IPO Year
- OFLX 2005
- BNTC N/A
- Fundamental
- Price
- OFLX $35.30
- BNTC $13.24
- Analyst Decision
- OFLX
- BNTC Strong Buy
- Analyst Count
- OFLX 0
- BNTC 5
- Target Price
- OFLX N/A
- BNTC $26.00
- AVG Volume (30 Days)
- OFLX 22.3K
- BNTC 40.8K
- Earning Date
- OFLX 10-29-2025
- BNTC 09-25-2025
- Dividend Yield
- OFLX 3.85%
- BNTC N/A
- EPS Growth
- OFLX N/A
- BNTC N/A
- EPS
- OFLX 1.69
- BNTC N/A
- Revenue
- OFLX $100,700,000.00
- BNTC N/A
- Revenue This Year
- OFLX N/A
- BNTC N/A
- Revenue Next Year
- OFLX N/A
- BNTC N/A
- P/E Ratio
- OFLX $20.93
- BNTC N/A
- Revenue Growth
- OFLX N/A
- BNTC N/A
- 52 Week Low
- OFLX $28.12
- BNTC $8.06
- 52 Week High
- OFLX $57.81
- BNTC $17.15
- Technical
- Relative Strength Index (RSI)
- OFLX 57.66
- BNTC 59.72
- Support Level
- OFLX $34.25
- BNTC $12.57
- Resistance Level
- OFLX $37.50
- BNTC $13.33
- Average True Range (ATR)
- OFLX 1.08
- BNTC 0.60
- MACD
- OFLX 0.26
- BNTC 0.10
- Stochastic Oscillator
- OFLX 54.73
- BNTC 95.59
About OFLX Omega Flex Inc.
Omega Flex Inc is a manufacturer of flexible metal hoses, which is used in a variety of ways to carry gases and liquids within their particular applications. Omega sells its products under the TracPipe, CounterStrike, DoubleTrac, DEF-Trac and MediTrac brands. It serves various markets which include construction, manufacturing, transportation, petrochemical, pharmaceutical, and other industries. Geographically Omega Flex, Inc operates in the United States. The company derives revenues from the manufacture and sale of flexible metal hose and accessories.
About BNTC Benitec Biopharma Inc.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.